According to Bliss GVS Pharma's latest financial reports the company's current EPS (TTM) is $0.07003. In 2022 the company made an earnings per share (EPS) of $0.11 an increase over its 2021 EPS that were of $0.002630.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.07003 | -33.43% |
2022 | $0.11 | 3900.2% |
2021 | $0.002630 | -96.98% |
2020 | $0.08718 | -40.93% |
2019 | $0.15 | 54.44% |
2018 | $0.09557 | -48.05% |
2017 | $0.18 | 39.44% |
2016 | $0.13 |